Lobbying Filing Details
Total Spending
$60,000
Activities
3
Lobbyists
4
Gov't Entities
6
Filing Information
- Filing UUID:
3f2d5e8d-39df-460e-928b-7ffb42e09725- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 21, 2026 at 2:09 AM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Tazeen Ahmad
Registrant
CAPITOL HILL CONSULTING GROUP
Government Relations Firm
Washington, District of ColumbiaClient
TEVA PHARMACEUTICALS USA
Generic and biosimilar manufacturer.
District of Columbia, United States of AmericaLobbying Activities (3)
Activity 1
Health IssuesIssues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act. Issues related to generic drug review.
Lobbyists (4)
- BRIAN SUTTER
- EMILY ELIZABETH WILKINSON-HOLLAND
- MR. CHRISTOPHER DAVIS
- KIMBERLEE TRZECIAK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Medicare/MedicaidIssues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.
Lobbyists (4)
- BRIAN SUTTER
- EMILY ELIZABETH WILKINSON-HOLLAND
- MR. CHRISTOPHER DAVIS
- KIMBERLEE TRZECIAK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Trade (domestic/foreign)Issues related to potential tariffs on generic drugs.
Lobbyists (4)
- BRIAN SUTTER
- EMILY ELIZABETH WILKINSON-HOLLAND
- MR. CHRISTOPHER DAVIS
- KIMBERLEE TRZECIAK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES